About FDA

FDA Transparency Initiative Overview

The FDA launched a Transparency Initiative in June 2009.  The Transparency Initiative had three phases. More information, reports, and progress reports are available in the FDA Archive.

Phase I: FDA Basics - In January 2010, FDA launched a web-based resource called FDA Basics, which provides the public with basic information about FDA.

Phase II: Public Disclosure - In May 2010, the Task Force released the Phase II Transparency Report, which focused on disclosing certain information about FDA-regulated products and firms.

Phase III: Transparency to Regulated Industry - In January 2011, the Task Force released the Phase III Transparency Report, which focused on increasing the transparency of FDA operations and decision-making.

FDA implemented the action items and many of the draft proposals in the Phase II and Phase III Reports.

Transparency Report on Compliance and Enforcement Activity

  • On April 22, 2014, FDA released a report recommending ways to enhance the transparency and public accessibility of the agency's compliance and enforcement data.

Report on Good Guidance Practices

In December 2011, FDA issued a report focused on improving the transparency and efficiency of the Agency's guidance development processes.

 More Information

 



 

Page Last Updated: 12/13/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English